Stark H - Search Results

1

Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H₃ receptor ligands.

Szczepańska K, Karcz T, Siwek A, Kuder KJ, Latacz G, Bednarski M, Szafarz M, Hagenow S, Lubelska A, Olejarz-Maciej A, Sobolewski M, Mika K, Kotańska M, Stark H, Kieć-Kononowicz K. Szczepańska K, et al. Among authors: stark h. Bioorg Chem. 2019 Oct;91:103071. doi: 10.1016/j.bioorg.2019.103071. Epub 2019 Jun 20. Bioorg Chem. 2019. PMID: 31362197

2

Azines and diazines as potential histamine H3-receptor antagonists.

Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W. Kieć-Kononowicz K, et al. Among authors: stark h. Arch Pharm (Weinheim). 1995 May;328(5):445-50. doi: 10.1002/ardp.19953280509. Arch Pharm (Weinheim). 1995. PMID: 7611840

3

Development of a binding site model for histamine H3-receptor agonists.

Sippl W, Stark H, Höltje HD. Sippl W, et al. Among authors: stark h. Pharmazie. 1998 Jul;53(7):433-7. Pharmazie. 1998. PMID: 9699219

4

General construction pattern of histamine H3-receptor antagonists: change of a paradigm.

Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2011-6. doi: 10.1016/s0960-894x(98)00342-4. Bioorg Med Chem Lett. 1998. PMID: 9873477

5

Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.

Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W. Sasse A, et al. Among authors: stark h. J Med Chem. 1999 Feb 25;42(4):593-600. doi: 10.1021/jm9804376. J Med Chem. 1999. PMID: 10052966

6

(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.

Sasse A, Stark H, Ligneau X, Elz S, Reidemeister S, Ganellin CR, Schwartz JC, Schunack W. Sasse A, et al. Among authors: stark h. Bioorg Med Chem. 2000 May;8(5):1139-49. doi: 10.1016/s0968-0896(00)00050-x. Bioorg Med Chem. 2000. PMID: 10882024

7

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.

Stark H, Ligneau X, Sadek B, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 2000 Oct 16;10(20):2379-82. doi: 10.1016/s0960-894x(00)00473-x. Bioorg Med Chem Lett. 2000. PMID: 11055360

8

Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine.

Stark H, Krause M, Rouleau A, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem. 2001 Jan;9(1):191-8. doi: 10.1016/s0968-0896(00)00237-6. Bioorg Med Chem. 2001. PMID: 11197341

9

Different antagonist binding properties of human and rat histamine H3 receptors.

Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 2001 Apr 9;11(7):951-4. doi: 10.1016/s0960-894x(01)00090-7. Bioorg Med Chem Lett. 2001. PMID: 11294398

10

Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.

Łazewska D, Kieć-Kononowicz K, Pertz HH, Stark H, Schunack W, Elz S. Łazewska D, et al. Among authors: stark h. Pharmazie. 2001 Dec;56(12):927-32. Pharmazie. 2001. PMID: 11802653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,175 results

Search Page